Unknown

Dataset Information

0

Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease.


ABSTRACT: INTRODUCTION:The safety and efficacy of exenatide once weekly (EQW) is overall well established. EQW is primarily renally eliminated. In this study, the efficacy and renal and gastrointestinal tolerability of EQW were summarised in participants with type 2 diabetes and chronic kidney disease stage 3 (CKD3; moderate renal impairment; estimated glomerular filtration rate [eGFR]???30 to?

SUBMITTER: Guja C 

PROVIDER: S-EPMC7324446 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease.

Guja Cristian C   Frías Juan P JP   Suchower Lisa L   Hardy Elise E   Marr Galina G   Sjöström C David CD   Jabbour Serge A SA  

Diabetes therapy : research, treatment and education of diabetes and related disorders 20200418 7


<h4>Introduction</h4>The safety and efficacy of exenatide once weekly (EQW) is overall well established. EQW is primarily renally eliminated. In this study, the efficacy and renal and gastrointestinal tolerability of EQW were summarised in participants with type 2 diabetes and chronic kidney disease stage 3 (CKD3; moderate renal impairment; estimated glomerular filtration rate [eGFR] ≥ 30 to < 60 mL/min/1.73 m<sup>2</sup>) or CKD stage 2 (CKD2; mild renal impairment; eGFR ≥ 60 to < 90 mL/min/1.7  ...[more]

Similar Datasets

| S-EPMC7078076 | biostudies-literature
| S-EPMC5565650 | biostudies-other
| S-EPMC3308312 | biostudies-literature
| S-EPMC5724491 | biostudies-literature
| S-EPMC4621218 | biostudies-literature
| S-EPMC6150435 | biostudies-other
| S-EPMC4445788 | biostudies-literature
| S-EPMC5485171 | biostudies-literature
| S-EPMC5969323 | biostudies-literature
| S-EPMC6168745 | biostudies-literature